0 -diphosphate-N-acetylglucosamine (UDP-GlcNAc) acyltransferase (LpxA) catalyzes a reversible reaction for adding an O-acyl group to the GlcNAc in UDP-GlcNAc in the first step of lipid A biosynthesis. Lipid A constitutes a major component of lipopolysaccharides, also referred to as endotoxins, which form the outer monolayer of the outer membrane of Gramnegative bacteria. Ligand-free and UDP-GlcNAc-bound crystal structures of LpxA from Bacteroides fragilis NCTC 9343, the most common pathogenic bacteria found in abdominal abscesses, have been determined and are presented here. The enzyme crystallizes in a cubic space group, with the crystallographic threefold axis generating the biological functional homotrimer and with each monomer forming a nine-rung left-handed -helical (LH) fold in the N-terminus followed by an -helical motif in the C-terminus. The structure is highly similar to LpxA from other organisms. Yet, despite sharing a similar LH structure with LpxAs from Escherichia coli and others, previously unseen calcium ions are observed on the threefold axis in B. fragilis LpxA to help stabilize the trimeric assembly.
Introduction
Uridine 5 0 -diphosphate-N-acetylglucosamine (UDP-GlcNAc) acyltransferase (LpxA) catalyzes a reversible reaction for adding an O-acyl group to the GlcNAc in UDP-GlcNAc in the first step of lipid A biosynthesis (Fig. 1) . Although LpxA is present in all Gram-negative bacteria, its substrate preference towards specific acyl chains varies for different species. LpxA from Bacteroides fragilis NCTC 9343 is most likely to prefer the 15-carbon saturated fatty acid-acyl carrier protein since the structure of its lipid A was determined to have a C 15 fattyacyl group at the 3-OH position of the GlcNAc in UDPGlcNAc (Berezow et al., 2009) .
Lipid A is a highly acylated glycophospholipid that is a major component and serves as the hydrophobic anchor of lipopolysaccharides (LPSs) for most Gram-negative bacteria (Raetz et al., 2007) . LPSs are often referred to as endotoxins because of their immune-activating effects on mammalian host systems (Masoudi et al., 2014) . The development of detoxified forms of lipid A could provide vaccine adjuvants and immunostimulants. For example, Toll-like receptor (TLR)-activating lipid IVa and synthetic mimetics have been developed to decrease the risk of inflammatory side effects (Saitoh et al., 2004; Hashimoto et al., 2002) . Gram-negative bacteria also have the ability to modify the structures of lipid A, which may be related to their evolutionary survival or manipulation of the host innate immune response, but the mechanism is not well understood. One example has been shown for Salmonella typhimurium, which can modify its lipid A by adding an amino-arabinose to the 4 0 -phosphate of lipid A, which resulted in conferring resistance to the antimicrobial peptide polymyxin (Gunn et al., 1998) .
Bacteria strongly rely on the integrity of the amphipathic outer membrane for survival. The opportunistic B. fragilis is an anerobic microbe that constitutes only 1-2% of the human gastrointestinal tract flora; however, it is the predominant isolate in abdominal abscesses and soft-tissue infections and has the highest polysaccharide capsule diversity among Gramnegative bacteria (Pumbwe et al., 2006; Patrick et al., 2010) . In addition, cases of lethal multidrug-resistant strains of B. fragilis have been reported (Katsandri et al., 2006; Wareham et al., 2005) and efforts to identify the antimicrobial resistant genes have been published (Sydenham et al., 2015) . Our historic reliance on antibiotics for combating bacterial infections has led to the evolution of antibiotic-resistant pathogenic bacteria. Therefore, there is an urgent need to develop new drugs for the treatment of bacterial infectious diseases. One approach is to design inhibitors specific for the enzymes involved in the biosynthetic pathway of cell-wall synthesis belonging to Gram-negative bacteria. LpxA, which catalyzes the first step in lipid A biosynthesis (Coleman & Raetz, 1988) , is an excellent target for the development of antimicrobial drug candidates.
LpxA also has unique structural features. It belongs to the unique left-handed parallel -helix (LH) protein superfamily which has an LH structural domain containing multiple imperfect tandem-repeated six-residue motifs (Raetz & Roderick, 1995) . In addition to LpxA, the LH domain has also been identified in another acyltransferase, LpxD, involved in lipid A biosynthesis Bartling & Raetz, 2009; Badger et al., 2011) , -class carbonic anhydrases (Kisker et al., 1996; Jeyakanthan et al., 2008) and other acyltransferases including tetrahydrodipicolinate (THDP) N-succinyltransferases (Beaman et al., 1997) , xenobiotic acetyltransferases (Beaman et al., 1998) , bifunctional glucosamine-1-phosphate (GlcN-1-P) acetyltransferase and N-acetylglucosamine-1-phosphate (GlcNAc-1-P) uridyltransferase (GlmU; Brown et al., 1999) , another UDP-sugar N-acetyltransferase from Campylobacter jejuni (PglD; Rangarajan et al., 2008) , antibiotic acetyltransferases (Sugantino & Roderick, 2002; Kehoe et al., 2003) , serine acetyltransferases (Olsen et al., 2004) , the bacterial sialic acid-containing polysaccharide O-acetyltransferases OatWY (Lee et al., 2009) and NeuO (Schulz et al., 2011) , galactoside acetyltransferases (Wang et al., 2002) and maltose acetyltransferases (Lo Leggio et al., 2003) . Recently, the first triangular-fold LH domain has been structurally confirmed in a human protein, a p27 subunit (PDB entry 3tv0; Z. S. Derewenda, U. Derewenda, A. Kowalska & M. Zheng, unpublished work) that acts as part of the dynactin protein complex involved in the in vivo function of a microtubule (MT)-based motor for mitosis (Yeh et al., 2013) . Other human proteins that have been predicted, but not confirmed, to contain the LH fold are the dynactin p25 subunit, eukaryotic translation initiation factor 2B "-and -subunits and GDPmannose pyrophosphorylases A and B (Choi et al., 2008) . A significant structural difference between Escherichia coli LpxA (EcLpxA) and the p27 subunit is the lack of an -helical cap in the C-terminus of the p27 domain. In addition, p27 does not form a homotrimer as is found in LpxA, but instead exists as a heterodimer with a different protein, a p25 subunit. Since this newly determined crystal structure of the human LH protein possesses structural similarity to LpxA, a potential antimicrobial drug target, it is essential to identify structural differences between the human and bacterial proteins and to test drugs that are selective against bacterial LpxAs (Yeh et al., 2013) .
The crystal structures of LpxAs from the pathogenic bacteria E. coli (Raetz & Roderick, 1995; Ulaganathan et al., 2007) , Helicobacter pylori (Lee & Suh, 2003) , Acinetobacter baumannii (Badger et al., 2012) , Leptospira interrogans (Robins et al., 2009) , Burkholderia thailandensis (Baugh et al., 2013) and C. jejuni (PDB entry 3r0s; Center for Structural Genomics of Infectious Diseases, unpublished work), as well as the plant Arabidopsis thaliana (Joo et al., 2012) , have been reported. Although these LpxAs share a high degree of sequence homology and display similar three-dimensional structures, the LpxAs from different species vary in their selectivity towards acyl chains of various lengths and structures. For example, E. coli LpxA (EcLpxA) prefers the 14-carbon fatty acid (R)-3-hydroxymyristoyl chain, Chlamydia trachomatis LpxA prefers the 14-carbon myristoyl chain and H. pylori LpxA (HpLpxA) prefers the 16-carbon (R)-3-hydroxypalmitoyl chain (Sweet et al., 2001; Lee & Suh, 2003) . The difference in the acyl-chain length and structure in the lipid A structures of B. fragilis and B. thetaiotaomicron may contribute to the varied degrees of toxicity of these two closely related species (Berezow et al., 2009 
Figure 1
The reversible UDP-GlcNAc acylation reaction catalyzed by B. fragilis LpxA. Abbreviations: 3-OH-C15-ACP, 3-hydroxypentadecanoic fatty acid-acyl carrier protein; LpxA, UDP-GlcNAc acyltransferase. Table 1 . PCR was performed in a reaction mixture (50 ml) containing genomic DNA (100 ng), forward and reverse primers (0.2 mM each), 1Â Herculase II buffer, dNTP mixture (1 mM) and 5 U (1 ml) Herculase II DNA polymerase (Agilent Technologies, Santa Clara, California, USA). The reaction was subjected to 30 cycles of amplification at an annealing temperature of 50 C. The resulting PCR product was digested with NdeI and BamHI restriction enzymes and inserted into pET-15b expression vector pre-digested with the same restriction enzymes to construct a plasmid to express N-terminally His 6 -tagged recombinant BfLpxA. BfLpxA was overexpressed in E. coli BL21 (DE3) cells. The cells were grown at 37 C in Luria-Bertani medium containing ampicillin (100 mg l
À1
) until the OD 600 nm of the culture reached 0.6. Expression of the protein was induced by adding isopropyl -d-1-thiogalactopyranoside (IPTG) to a final concentration of 0.1 mM followed by incubation of the culture at 37 C for 3 h. To harvest the cells, the culture was centrifuged at 4000 rev min À1 for 2 h and the cell pellet was resuspended in lysis buffer (100 mM Tris-HCl pH 8.0, 0.1% Triton X-100; 20 ml per litre of cell culture) followed by freezing at À80 C overnight. Cell lysis was performed by thawing the frozen cells at 37 C and adding lysozyme (0.3 mg ml
) and DNaseI (18 mg ml 
, where hI(hkl)i is the mean of i observations I i (hkl) of reflection hkl. ‡ R factor and R free = P hkl jF obs j À jF calc j = P hkl jF obs j Â 100 for 95% of the recorded data (R factor) or for 5% of the data, which were omitted from refinement (R free ). § Ramachandran plot statistics are from the PDB submission validation report.
Tris-HCl, 0.5 M NaCl, 5 mM imidazole pH 7.5) in a 10 Â 1.5 cm column. The bound BfLpxA was washed with eight column volumes of binding buffer and eight column volumes of washing buffer (50 mM Tris-HCl, 0.5 M NaCl, 35 mM imidazole pH 7.5). The protein was eluted with elution buffer (50 mM Tris-HCl, 0.5 M NaCl, 200 mM imidazole pH 7.5). Fractions containing protein were pooled and dialyzed against 20 mM Tris-HCl buffer pH 7.5 using 10 kDa dialysis membrane tubing. The concentration of the purified protein was determined with a bicinchoninic acid (BCA) Protein Assay Kit (Pierce Biotechnology, Rockford, Illinois, USA) using bovine serum albumin (BSA) as the protein standard. The absorbance of the samples was measured in a 96-well microplate at 562 nm using a BioTek Synergy HT Multi-Mode Microplate Reader. Generally, each litre of expression medium produced 90 mg purified protein.
Crystallization and X-ray data collection
Initial screening for crystallization conditions was performed using the Wizard Classic 1, Classic 2, Cryo 1 and Cryo 2 crystallization screens (Rigaku). Optimized crystal- BfLpxA functional trimer with bound UDP-GlcNAc (white space-filling atoms) and a Ca 2+ cation (gold) on the crystallographic threefold axis. The view in (a) is down the crystallographic threefold axis of the trimer generated by the A subunit; that in (b) shows the same trimer rotated 90 so that the crystallographic threefold axis is vertical. Table 2 ). The sitting drop was prepared by mixing 2 ml reservoir solution with 2 ml protein solution (7.5 mg ml À1 ) and was equilibrated against 0.5 ml reservoir solution. The condition that resulted in the highest quality crystals was 28% PEG 600, 200 mM calcium acetate, 100 mM sodium cacodylate pH 6.5. To generate the binary complex of BfLpxA with UDP-GlcNAc, the crystal was soaked with 15 mM UDPGlcNAc for 30 min prior to crystal cryocooling. Crystals were flash-cooled directly from the mother liquor.
X-ray diffraction data were collected on beamline 7-1 at Stanford Synchrotron Radiation Lightsource (SSRL) using an ADSC Q315r CCD detector. The crystals were exposed for 4 s for each 0.3 crystal rotation. Diffraction intensity data were integrated with XDS (Kabsch, 2010) and scaled with AIMLESS (Evans & Murshudov, 2013; Winn et al., 2011) .
Structure solution and refinement
The ligand-free structure was solved by molecular replacement with Phaser (McCoy, 2007) using the previously determined structure of EcLpxA (PDB entry 1lxa; Raetz & Roderick, 1995) . The model was built using the molecular-modeling program Coot (Emsley & Cowtan, 2004) and was refined using PHENIX (Adams et al., 2010) . The UDP-GlcNAc-bound structure was solved by initially refining the ligandfree structure (without any solvent molecules) against diffraction data from UDP-GlcNAc-soaked crystals and using Coot to build in the UDP-GlcNAc substrate. Numerous rounds of refinement with subsequent model adjustment and solvent addition were then carried out for the UDP-GlcNAcbound binary structure. Both the ligand-free and the UDPGlcNAc-bound binary structures were refined to 1.90 Å resolution. The final data-collection and refinement statistics are listed in Table 3 .
Results and discussion

Crystallization of BfLpxA and soaking with UDP-GlcNAc
BfLpxA was crystallized using 28%(w/v) PEG 600, 200 mM calcium acetate, 100 mM sodium cacodylate pH 6.5. The crystals (Fig. 2) belonged to the cubic space group P4 1 32, with unit-cell parameter a = 149.05 Å (Table 3) . This results in two monomers per asymmetric unit (V M = 2.49 Å 3 Da À1 , 50.7% solvent content; Fig. 3 ; Matthews, 1968) . The ligand-free structure was solved by molecular replacement using the EcLpxA structure (PDB entry 1lxa) as a phasing model. Each monomer of the asymmetric unit is situated at the crystallographic threefold axis, generating the homotrimeric structure (Fig. 4) . The homotrimeric structure of BfLpxA is similar to the previously solved crystal structures of other LpxAs. Soaking the crystals in UDP-GlcNAc (15 mM) for 30 min prior to flash-cooling and data collection resulted in strong and well defined electron density corresponding to the entire UDP-GlcNAc molecule bound to the surface of the -helix (Fig. 4) . 
Figure 6
Protein sequence alignment of BfLpxA (GenBank accession No. Q5LH16) and EcLpxA (GenBank accession No. P0A722), which share 42% identity. Secondary-structure elements are drawn above the sequence. Residues that hydrogen-bond to the UDP-GlcNAc substrate are indicated with a green star, while Asn89, which coordinates the calcium ion at the threefold axis, is marked by a blue asterisk (the numbers reflect the BfLpxA sequence). This figure was generated using ESPript 3.0 (Robert & Gouet, 2014 
BfLpxA apo structure
The BfLpxA apo structure is a homotrimer with a nine-rung left-handed -helical (LH) fold in the N-terminus with two loops extending from rungs three and four followed by an -helical motif in the C-terminus (Fig. 4) . The crystal structure is highly similar to and aligns well with that of EcLpxA (PDB entry 1lxa). The EcLpxA structure consists of 18 amino acids per rung and six amino acids per turn in the LH region, as shown in the structural alignment of the monomer with BfLpxA (Fig. 5) . BfLpxA is six amino acids shorter than EcLpxA and its N-terminus is found in the second short -strand when the sequence is aligned with that of EcLpxA (Fig. 6) . Each complete rung consists of three short -strands constructed from imperfect hexapeptide repeats. The sixresidue sequence motif in BfLpxA is generally (I/V)-XXX-(A/ V/N/C)-X, where the first position I/V is Ile or Val and forms an internal facing hydrophobic ladder and the fifth position is generally occupied by a small residue (Ala, Val, Ser, Thr or Cys) also facing inside the LH. Sequence-homology alignment using Clustal Omega yields 41.96% identity between EcLpxA and BfLpxA (Fig. 6) . Superposition of EcLpxA with BfLpxA in PyMOL yields a root-mean-square difference (r.m.s.d.) of 0.950 Å for 243 C -atom pairs.
BfLpxA complex with UDP-GlcNAc
Previous reports on EcLpxA have shown that its active site is located at the subunit-subunit interface, where UDPGlcNAc binds (Ulaganathan et al., 2007) . This is also the case for BfLpxA (Fig. 7) . The 1.90 Å resolution crystal structure of BfLpxA soaked with UDP-GlcNAc revealed the substrate bound to only one monomer of the asymmetric unit because the active site of the other monomer was blocked by crystal contacts. The uracil base of the UDP-GlcNAc is sandwiched Figure 7 Binding of UDP-GlcNAc at the interface between two monomers within the active trimer. (a) Simulated-annealed OMIT map contoured at 2.5 showing the unbiased positive F o À F c electron density around the UDP-GlcNAc substrate. Side chains are omitted for clarity. (b) Amino-acid residues Arg197 and Asn191 from subunit A1 (magenta) of BfLpxA interact with the uracil and diphosphate of UDP-GlcNAc. Amino-acid residues Lys70, His118, Leu69 and Gln154 from subunit A (blue) of BfLpxA interact with the -phosphate and GlcNAc of UDP-GlcNAc. Also shown are ordered solvent molecules (red spheres) that interact with UDP-GlcNAc, and the acetate ion (ACT). (c) Surface rendering at the interface with UDP-GlcNAc positioned between subunit A and the threefold-related partner subunit A1 of the BfLptA trimer. between Met163 and Ile193 from the -helical region of one subunit (subunit A1). Additionally, two amino-acid residues, Asn191 and Arg197 of subunit A1, interact with the UDP (Fig. 7) . Asn191 hydrogen-bonds to N3 and O4 of the uracil and Arg197 interacts with three phosphate O atoms: one each from the -and -phosphates and the O atom between the -phosphate and the ribose (Fig. 7) . Gln154 extends from coil 8 of the neighboring threefold-related subunit (subunit A) and interacts with an O atom of the -phosphate as well as the bridging O atom between the -and -phosphates (Fig. 7) . Three amino acids from subunit A interact with the GlcNAc moiety as follows. His118 is the general base that generates the nucleophile on the 3-hydroxyl group and also appears to interact with the 4-hydroxyl group of GlcNAc in UDPGlcNAc (Fig. 7) . This is similar to the general base-catalyzed mechanism of His125 of EcLpxA; however, His125 in EcLpxA does not interact with the 4-hydroxyl of GlcNAc in UDPGlcNAc (Ulaganathan et al., 2007) . Leu69 and Lys70 both extend from loop 1 (from subunit A1), where the main-chain N atom of Leu69 interacts with the N-acetyl group of UDPGlcNAc and N of Lys70 interacts with the ring O atom and 6-hydroxyl group of GlcNAc in UDP-GlcNAc. BfLpxA shares many of the conserved residues, Asn198, Arg204, Gln161, His125, Lys76 and Leu75, found in EcLpxA (Ulaganathan et al., 2007) , which are analogous to Asn191, Arg197, His118, Lys70 and Leu69 in BfLpxA. Arg204 of EcLpxA forms hydrogen bonds to O2 and N3 of the uracil (Ulaganathan et al., 2007) . However, in BfLpxA the corresponding Arg198 is not within contact range of the uracil. Also, Arg204 of EcLpxA only interacts with the -phosphate (Ulaganathan et al., 2007) , whereas the corresponding Arg197 in BfLpxA interacts with O atoms on both the -and -phosphates. Extended tubular electron density was found between the -helix of one subunit and the loops of a symmetry-related subunit, which we modeled as a polyethylene glycol (PEG) molecule. The PEG molecule resides on the outer face of the homotrimer opposite to the active binding site of UDPGlcNAc (Fig. 8) . This electron density is not likely to be an acyl-chain substrate since it is not located near the active cleft and no lipids or detergents were used in crystallization. The observed PEG comes from the crystallization solution, and its location suggests that it plays an important role in the formation and maintenance of the crystal lattice.
Strong electron density in the shape of a flat triangle observed near the UDP-GlcNAc active site at the interface between two subunits was modeled as an acetate ion, which was present in the crystallization condition. This acetate ion is seen in both active sites in the asymmetric unit, and is observed even in the absence of UDP-GlcNAc substrate. The acetate ion forms hydrogen bonds to N "2 of His115 and O "1 of Gln67 of one subunit and N 2 of Asn130 from another trimerrelated subunit. When superimposed on EcLpxA with the bound product UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc, the acetate molecule aligns near C3 of the 3-hydroxymyristoyl-GlcNAc fatty-acyl chain (Fig. 9) . The acetate O atom that hydrogen-bonds to Gln67 and His115 in BfLpxA superimposes almost exactly on the O atom of the 3-hydroxyl group, which may reflect the preference of LpxAs towards 3-hydroxy-containing fatty-acyl chains in the substrate.
Strong electron density situated on the crystallographic threefold axis for each trimeric complex was modeled as a calcium cation (with an occupancy of 0.33; Fig. 10 ; Ca 2+ 1 and Ca 2+ 3 in Fig. 3 ). This ion is coordinated by O 1 of Asn89 from each monomer in the trimer with a ligand distance of 2.3 Å . Additionally, three water molecules (one from each asymmetric unit) are at 2.4 Å from the calcium cation. Finally, a more distant water ligand is also situated on the crystallographic threefold axis and is 2.8 Å away from the calcium cation to complete the coordination with the geometry of a capped trigonal biprism (Glusker, 1991) .
While no previous LpxA structures contained a divalent cation at the threefold axis, the presence of a divalent ion situated on the threefold axis of other left-handed -helical folds is observed in N-acetylglucosamine-1-phosphate uridyltransferase (GlmU) structures (Mochalkin et al., 2007 (Mochalkin et al., , 2008 Sulzenbacher et al., 2001; Olsen et al., 2007; Doig et al., 2014; Olsen & Roderick, 2001; Jagtap et al., 2013; Kostrewa et al., 2001) and that of -class carbonic anhydrase (Jeyakanthan et al., 2008) .
The LpxA structure also contains another calcium ion (Ca 2+ 2 in Fig. 3) , which is located between the -helical region of subunit B and rungs 4-5 of the LH of subunit A. This calcium is coordinated by seven water molecules and is involved in mediating crystal packing because residues from subunits A and B hydrogen-bond to the water ligands of the calcium. The crystallization buffer contained 0.2 M calcium acetate, and the exact role of Ca 2+ in the structure and function of BfLpxA is unknown.
Conclusion
In conclusion, BfLpxA shares a similar active site with known LpxAs such as that from E. coli. Their crystal structures appear to align well despite their selectivity towards acyl chains of different lengths and structures. The active site is composed of two neighboring subunits in which one subunit interacts with the UDP and the partner subunit interacts with the GlcNAc moiety with some shared interactions on the diphosphate. His118 is the general base that generates the 
Figure 9
The acetate ion (ACT; stick representation with white C atoms) found in BfLpxA (magenta) aligns near C3 of the hydroxymyristoyl chain of the product (olive-green sticks) bound to EcLpxA (green). Gln67 and His115 interact with the acetate along with Asn130 from a trimer-related subunit. The UDP-GlcNAc bound to BfLpxA is also shown in stick representation with white C atoms.
Figure 10
Calcium ligation at the trimer interface of BfLpxA. The calcium ion (small green sphere) is situated on the crystallographic threefold axis (vertical in the plane of the figure) and is ligated by Asn89 from each subunit and three water ligands (small red spheres). A fourth water molecule also lies on the crystal threefold axis above the calcium ion. Numbers represent distances in Å . nucleophile on the 3-hydroxyl group and also appears to interact with the 4-hydroxyl group of the GlcNAc in UDPGlcNAc. This is the first crystal structure of LpxA with calcium cations bound. Asn89 of BfLpxA, which coordinates the calcium ion, is a serine in EcLpxA and may explain the absence of calcium in this enzyme. The calcium cations may come from the calcium acetate buffer used in the crystallization conditions, but their exact role, if any, is unknown.
